 |
antinuclear antibody conjugated liposomal doxorubicin |
|---|---|
| Trade Name | |
| Orphan Indication | Ewing's sarcoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-02-03 00:00:00 |
| Sponsor | NanoSmart Pharmaceuticals, Inc.;27071 Cabot Road, Suite 104;Laguna Hills, California, 92653 |
